The Latest Breaking News from Boehringer Ingelheim

For decades, psychiatrists have treated psychosis as if it were separate conditions. People experiencing hallucinations and delusions might be diagnosed with schizophrenia, bipolar disorder, severe depression and related diagnoses, and receive completely different treatments based on diagnosis. But new research suggests this approach may be fundamentally flawed.

Silicosis is an incurable but entirely preventable lung disease. It has only one cause: breathing in too much silica dust. This is a risk in several industries, including tunnelling, stone masonry and construction.

A major deal with a pharmaceutical company will ensure Australia has access to antigens and vaccines to defend itself against a foot-and-mouth disease outbreak.

Boehringer Ingelheim announces layoffs due to poor biosimilar sales of Humira, emphasizing commitment to R&D for future growth.